Serum neurofilament light chain concentration in a phase 1/2 trial of autologous mesenchymal stem cell transplantation

BACKGROUND: Serum neurofilament light chain concentration is a proposed biomarker of axonal injury in multiple sclerosis. Mesenchymal stem cells have anti-inflammatory and repair-promoting activities, making them of interest for potential multiple sclerosis treatment. OBJECTIVES: The purpose of this...

Descripción completa

Detalles Bibliográficos
Autores principales: Baldassari, Laura E, Planchon, Sarah M, Bermel, Robert A, Nakamura, Kunio, Fisher, Elizabeth, Feng, Jenny, Sakaie, Ken E, Ontaneda, Daniel, Cohen, Jeffrey A
Formato: Online Artículo Texto
Lenguaje:English
Publicado: SAGE Publications 2019
Materias:
Original Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6831979/
https://www.ncbi.nlm.nih.gov/pubmed/31723439
http://dx.doi.org/10.1177/2055217319887198

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6831979/
https://www.ncbi.nlm.nih.gov/pubmed/31723439
http://dx.doi.org/10.1177/2055217319887198

Ejemplares similares